menu
    • menu

    Company profile for Grunenthal

    NEW Drugs in Dev: 35
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    As a true global partner, we know how to bring products to market at competitive cost, with current deliveries spanning well over 100 countries worldwide. Grünenthal PRO offers a unique combination of highly efficient production, with very high standards of quality and service level. We are able to adapt and segment our operation to different business models, from high volume generics, to high complexity portfolio driven busi...
    As a true global partner, we know how to bring products to market at competitive cost, with current deliveries spanning well over 100 countries worldwide. Grünenthal PRO offers a unique combination of highly efficient production, with very high standards of quality and service level. We are able to adapt and segment our operation to different business models, from high volume generics, to high complexity portfolio driven business models, as well as continuous improvement frameworks for the highly competitive biopharma market. As a family owned company, it is our long term commitment that drives sustainable partnerships with our customers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GrunenthalGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Zieglerstraße 6, 52078 Aachen
    Telephone
    Telephone
    + 49 241 569 3231
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.grunenthal.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gruenenthal
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/grunenthalgroup

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Grünenthal Licenses Qutenza Rights Exclusively in South Korea
    Grünenthal Licenses Qutenza Rights Exclusively in South Korea

    05 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grunenthal-licenses-exclusive-south-korean-rights-to-qutenza-to-bcworld-pharm-302705157.html

    PR NEWSWIRE
    05 Mar 2026
    Share Share
    Grünenthal Acquires Full Ownership Of Grünenthal Meds From Kyowa
    Grünenthal Acquires Full Ownership Of Grünenthal Meds From Kyowa

    02 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grunenthal-takes-full-ownership-of-grunenthal-meds-the-joint-venture-established-with-kyowa-kirin-for-its-established-medicines-brands-302700928.html

    PR NEWSWIRE
    02 Mar 2026
    Share Share
    Grünenthal Licenses Australian Rights to Qutenza to Clinect
    Grünenthal Licenses Australian Rights to Qutenza to Clinect

    24 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grunenthal-licenses-exclusive-australian-rights-to-qutenza-to-clinect-302695467.html

    PR NEWSWIRE
    24 Feb 2026
    Share Share
    Grünenthal Initiates Clinical Development Of Nav 1.8 Inhibitor
    Grünenthal Initiates Clinical Development Of Nav 1.8 Inhibitor

    18 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grunenthals-proprietary-nav-1-8-inhibitor-enters-clinical-development-302691460.html

    PR NEWSWIRE
    18 Feb 2026
    Share Share
    Apotex Licenses Rights to Testosterone Replacement therapy
    Apotex Licenses Rights to Testosterone Replacement therapy

    06 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grunenthal-licenses-exclusive-canadian-rights-to-testosterone-replacement-therapy-nebido-to-apotex-302680392.html

    PR NEWSWIRE
    06 Feb 2026
    Share Share
    Grünenthal Enhances Regulatory Management with Veeva
    Grünenthal Enhances Regulatory Management with Veeva

    25 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grunenthal-advances-global-regulatory-information-management-and-operations-with-veeva-302489570.html

    PR NEWSWIRE
    25 Jun 2025
    Share Share

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Grunenthal and get a quotation

    Grunenthal is a supplier offers 7 products (APIs, Excipients or Intermediates).

    Find Tramadol Hydrochloride bulk with CEP, JDMF offered by Grunenthal

    Find Tramadol Hydrochloride bulk with DMF offered by Grunenthal

    Find Betahistine Dihydrochloride bulk with CEP offered by Grunenthal

    Find Tapentadol bulk with CEP offered by Grunenthal

    Find Omeprazole bulk offered by Grunenthal

    Find Oxymorphone Hydrochloride bulk offered by Grunenthal

    Find Supidimide bulk offered by Grunenthal

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search